Navigation Links
Astaxanthin Stability Breakthrough Achieved by Valensa

ORLANDO, Fla., Aug. 19 /PRNewswire/ -- Valensa International announced today that it has developed technology that has dramatically increased the stability and shelf-life of the powerful, versatile antioxidant astaxanthin. The company has just completed a 7-year shelf-life study of its Zanthin(R) natural astaxanthin that indicates that this ultra-high pressure supercritical CO2 extract of Haematococcus pluvialis, bolstered by Valensa's proprietary O2B(R) Peroxidation Blocker technology, has a minimum 4-year shelf-life. Published reports by other astaxanthin producers indicate ranges of 1 - 2 years under refrigeration as the existing state-of-the-art for astaxanthin stability. Effective immediately, Valensa has raised its Zanthin(R) brand astaxanthin oleoresin stability recommendation to 4 years at 20 degrees C. The greater stability profile of Zanthin(R) astaxanthin will allow formulators of nutraceutical products to use smaller safety margins (overage) to assure consumers of efficacy in products on a store shelf, which can lead to cost savings.

According to Rudi E. Moerck, President & CEO of Valensa International, it is incumbent on producers of nutraceutical ingredients to manage the stability issues of their extracted products to assure safety and quality. "Anytime you extract oils or oleoresins from natural materials, you are faced with stability issues relating to oxidative degradation. At Valensa, we have developed a considerable body of expertise in addressing the stability of our extracted products, continually developing new extraction methodologies and developing customized stabilization packages that are natural and protect our products and the people who use them," he said. "The data in our just concluded study are a confirmation of why our customers put their trust in Zanthin(R) natural astaxanthin as the best and most stable astaxanthin ingredient on the market today. Essentially, we have been able to eliminate stability concerns and create a new level of astaxanthin shelf-life for our customers," he added. Moerck went on to point out that the company's position as a fully integrated supplier with chain of custody over raw materials growing and harvesting through the extraction process is the source for overall quality for its Zanthin(R) natural astaxanthin and contributes to the company's ability to manage shelf-life issues. Valensa now recommends a 5% safety margin, or "overage," for its astaxanthin as compared to the 10% the industry typically uses.

ZANTHIN(R) - A natural, high efficacy extract with proven quality

Valensa International is the world's leading manufacturer of finished form natural astaxanthin extract. It was the first company to have finished form material approved for use by regulatory agencies in both the United States and Europe. Valensa employs its proprietary DeepExtract(R) supercritical CO2 process to create the best quality materials and its O2B(R) Peroxidation Blocker stabilization technology to ensure long-term stability and efficacy for the consumer. The company employs dedicated organic certified facilities for the extraction of astaxanthin to ensure quality and avoid the potential for contamination by solvents or allergens that can occur when an astaxanthin extractor is also producing other products -- such as peanuts or shell-fish-based materials -- in the same equipment. Scientific studies of stability chemistry with extracted plant-derived oleoresins have allowed Valensa to move beyond ingredients such as safflower oil -- a diluent widely used in the industry and which that actually increases oxidative degradation -- to custom-tailored stabilization packages designed for the product in question.

For information on Zanthin(R) Natural Astaxanthin, please contact Valensa directly.

    For further information, contact:

    Rudi Moerck, President & CEO
    Voice: 352-357-2004
    Fax: 352-483-2095

This release was issued through eReleases(TM). For more information, visit

SOURCE Valensa International, LLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Valensa and Parry Nutraceuticals Introduce Organic SpiruZan(TM) Spirulina/Astaxanthin Complex as Lifestyle Support for a Fast-Paced World
2. Valensa Completes Second Expansion of Astaxanthin Capacity
3. Smith & Nephew Endoscopys BIORAPTOR(TM) 2.3 PK Suture Anchor Provides Secure Repair for Shoulder, Hip Instability
4. Aon Study Finds Stability in Nationwide Liability Costs in the Long Term Health Care Sector
5. Effect of mutant p53 stability on tumorigenesis and drug design
6. Unique skeletal muscle design contributes to spine stability
7. National Front Line Caregiver Group Urges Senate Leaders to Support Grassley Amendment Protecting Seniors Care, Assuring Stability of Nations Long Term Care Workforce
8. Studies evaluate the anatomy and stability of ACL reconstruction with different techniques
9. External focus improves postural stability in patients with Parkinsons disease
10. Covance Expands Analytical and Stability Service Capacity in North America
11. Morehead Presents Webinar on Preventing Physician Disloyalty: Building Stability and Trust with 'At-Risk' Physicians
Post Your Comments:
(Date:6/26/2016)... , ... June 26, 2016 , ... On June 10-11, ... of the 2016 Cereal Festival and World’s Longest Breakfast Table in Battle Creek, MI, ... the city’s history as home to some of the world’s leading providers of cereal ...
(Date:6/26/2016)... ... ... Kasmer, a legally blind and certified personal trainer is helping to develop a weight loss ... plans to fix the two major problems leading the fitness industry today:, ... , They don’t eliminate all the reasons people quit their exercise program ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery ... of Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , ... for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , ... Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , ... our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First ...
(Date:6/25/2016)... ... 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary of the ... to iHire in recognition of their exemplary accomplishments in worksite health promotion. , The ... Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Belgium , June 24, 2016 ... the appointment of Dr. Edward Futcher ... Non-Executive Director, effective June 23, 2016.Dr. Futcher was ... Nominations and Governance Committees.  As a non-executive member ... independent expertise and strategic counsel to VolitionRx in ...
(Date:6/23/2016)... Research and Markets has announced ... Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality ... - Global Forecast to 2021" report to their ... global pharmaceutical excipients market is projected to reach USD ... in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... June 23, 2016 Research and Markets ... Issue 52" report to their offering. ... treatment creates a favourable commercial environment for MedImmune to enter. ... base that will serve to drive considerable growth for effective ... serve to cap sales considerably, but development is still in ...
Breaking Medicine Technology: